These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15379130)

  • 1. [Prognostic value of a focal bone marrow lesion in diffuse large B-cell lymphosarcoma].
    Magomedova AU; Kremenetskaia AM; Vorob'ev IA; Kravchenko SK; Kaplanskaia IB; Samoĭlova RS; Gemdzhian EG; Vorob'ev AI
    Ter Arkh; 2004; 76(7):60-3. PubMed ID: 15379130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nine-year experience in the treatment of patients with diffuse large B-cell lymphosarcoma].
    Magomedova AU; Kravchenko SK; Kremenetskaia AM; Zvonkov EA; Bariakh EA; Mangasarova IaK; Kaplanskaia IB; Samoĭlova RS; Vorob'ev IA; Obukhova TN; Karagiulian SR; Shulutko EM; Galstian GM; Mar'in DS; Gabeeva NG; Vorob'ev AI
    Ter Arkh; 2011; 83(7):5-10. PubMed ID: 21894745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [International prognostic index in diffuse B large cell lymphosarcoma].
    Magomedova AU; Vorob'ev AI
    Ter Arkh; 2008; 80(3):71-6. PubMed ID: 18441690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma.
    Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A
    Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study.
    Talaulikar D; Dahlstrom JE; Shadbolt B; McNiven M; Broomfield A; Pidcock M
    Pathology; 2007 Dec; 39(6):580-5. PubMed ID: 18027262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.
    Campbell J; Seymour JF; Matthews J; Wolf M; Stone J; Juneja S
    Eur J Haematol; 2006 Jun; 76(6):473-80. PubMed ID: 16529599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The modified program NHL-BFM-90 in the treatment of patients with diffuse large B-cell lymphosarcoma].
    Magomedova AU; Kravchenko SK; Kremenetskaia AM; Zvonkov EE; Bariakh EA; Margolin OV; Kaplanskaia IB; Vorob'ev IA; Samoĭlova RS; Obukhova TN; Moiseeva TN; Zybunova EE; Gemdzhian EG; Vorob'ev AI
    Ter Arkh; 2006; 78(10):44-7. PubMed ID: 17180937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A CHOP-21 course efficacy in therapy of diffuse large B-cell lymphosarcoma].
    Magomedova AU; Kravchenko SK; Kremenetskaia AM; Zvonkov EE; Moiseeva TN; Zybunova EE; Kaplanskaia IB; Samoĭlova RS; Vorob'ev IA; Lorie IuIu; Margolin OV; Giliazitdinova EA; Gubkin AV; Chernova NG; Ryzhko VV; Gemdzhian EG
    Ter Arkh; 2005; 77(7):58-61. PubMed ID: 16116911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL).
    Mitterbauer-Hohendanner G; Mannhalter C; Winkler K; Mitterbauer M; Skrabs C; Chott A; Simonitsch-Klupp I; Gleiss A; Lechner K; Jaeger U
    Leukemia; 2004 Jun; 18(6):1102-7. PubMed ID: 15085149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
    Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
    Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma initially manifesting in the bone marrow.
    Kajiura D; Yamashita Y; Mori N
    Am J Clin Pathol; 2007 May; 127(5):762-9. PubMed ID: 17439835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
    Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry in the bone marrow staging of mature B-cell neoplasms.
    Stacchini A; Demurtas A; Godio L; Martini G; Antinoro V; Palestro G
    Cytometry B Clin Cytom; 2003 Jul; 54(1):10-8. PubMed ID: 12827663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective.
    Talaulikar D; Shadbolt B; Bell J; Khan K; Dahlstrom JE; McDonald A; Pidcock M; Broomfield A
    Histopathology; 2008 Feb; 52(3):340-7. PubMed ID: 18269585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse large B-cell lymphoma: clinical characterization and prognosis of Waldeyer ring versus lymph node presentation.
    Qi SN; Li YX; Wang H; Wang WH; Jin J; Song YW; Wang SL; Liu YP; Zhou LQ; Yu ZH
    Cancer; 2009 Nov; 115(21):4980-9. PubMed ID: 19634158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary breast lymphoma--a report of 27 cases with literature review].
    Cao YB; Wang SS; Huang HQ; Xu GC; He YJ; Guan ZZ; Lin TY
    Ai Zheng; 2007 Jan; 26(1):84-9. PubMed ID: 17222374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
    López-Guillermo A; Colomo L; Jiménez M; Bosch F; Villamor N; Arenillas L; Muntañola A; Montoto S; Giné E; Colomer D; Beà S; Campo E; Montserrat E
    J Clin Oncol; 2005 Apr; 23(12):2797-804. PubMed ID: 15728226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
    Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
    Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical course of 8 patients with intravascular large B-cell lymphoma diagnosed while alive].
    Ohshima R; Tomita N; Motohashi K; Ieda A; Hyou R; Fujisawa S; Fujita H; Sakai R; Koharazawa H; Kuwabara H; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 Jun; 46(6):453-7. PubMed ID: 16447727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.
    Sehn LH; Donaldson J; Chhanabhai M; Fitzgerald C; Gill K; Klasa R; MacPherson N; O'Reilly S; Spinelli JJ; Sutherland J; Wilson KS; Gascoyne RD; Connors JM
    J Clin Oncol; 2005 Aug; 23(22):5027-33. PubMed ID: 15955905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.